צמיחת הכנסות ב-12 חודשים נגררים: Portage Biotech Corp (PRTG)

Despite a lack of profitability and a reliance on investment, Portage Biotech Inc. (PRTG) operates within the protected medical innovation sector, which remains insulated from macroeconomic fluctuations. The rolling 12-month sales growth rate compared to the previous year demonstrates current trends, where the 0.00 mark reflects the latest data. Portage Biotech Inc. (PRTG) is developing immunotherapy to combat solid tumors, targeting the checkpoint inhibitor market and patients with resistant forms of cancer.
Portage Biotech Inc. - פילוחים אנליטיים ומדדי מפתח (PRTG)

This indicator measures revenue dynamics over the last twelve months relative to the same period last year, allowing for an assessment of the stability of customer demand and the pace of business expansion. Analyzing the annual sales growth rate over a 12-month period is critically important for Portage Biotech Inc. (PRTG), as turnover volatility during the NKT-asset development stage may signal risks or, conversely, an increase in investment attractiveness for acquisition by pharma behemoths.